ESTA NASDAQ
Establishment Labs Holdings Inc.
1W: +9.6%
1M: +2.5%
3M: -27.2%
YTD: -2.8%
1Y: +36.4%
3Y: +96.8%
5Y: -13.5%
$66.95
+1.17 (+1.78%)
Weekly Expected Move ±6.8%
$55
$59
$64
$68
$72
Credit Risk of going bust: lower than 52% of companies Debt: 11.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.95 (down 99%), Establishment Labs Holdings Inc. would be worth roughly what it owes.
Total debt $263.7M against a stock market value of $2.00B.
Distance to default 5.37 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $130.9M (short-term plus half of long-term), stock volatility 53.5%; Altman Z 2.69. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.95 (down 99%), Establishment Labs Holdings Inc. would be worth roughly what it owes.
Total debt $263.7M against a stock market value of $2.00B.
Distance to default 5.37 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $130.9M (short-term plus half of long-term), stock volatility 53.5%; Altman Z 2.69. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (56)
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
Establishment Labs a new Buy at Stifel on end-market prospects
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from Brokerages
Bank of New York Mellon Corp Purchases New Stake in Establishment Labs Holdings Inc. $ESTA
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from Brokerages
Deutsche Bank AG Buys New Holdings in Establishment Labs Holdings Inc. $ESTA
Establishment Labs signals $269M-$271M 2026 revenue as minimally invasive approaches 15% of sales
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates
AlTi Global Inc. Makes New Investment in Establishment Labs Holdings Inc. $ESTA
A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction.
Establishment Labs to join Russell 2000 Index
Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story
ESTA Q1 2026 Earnings Transcript
Jazz, AstraZeneca, Astellas: Foreign Healthcare's strongest Quant picks
Earnings Scheduled For May 6, 2026
Establishment Labs targets $266.5M-$268.5M 2026 revenue as minimally invasive revenue forecast rises above $35M
Establishment Labs Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
Establishment Labs GAAP EPS of -$0.45 misses by $0.09, revenue of $59.9M beats by $2.47M
Is Establishment Labs Holdings Inc. (ESTA) A Good Stock To Buy Now?
Establishment Labs secures $300M loan facility
Establishment Labs (NASDAQ:ESTA) Director Quiros Juan Jose Chacon Sells 30,178 Shares
Establishment Labs (NASDAQ:ESTA) Director Quiros Juan Jose Chacon Sells 42,642 Shares of Stock
Establishment Labs (NASDAQ:ESTA) Director Quiros Juan Jose Chacon Sells 2,180 Shares
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Establishment Labs Insider Sells 37,500 Shares as Stock Jumps 128% in a Year
Establishment Labs (NASDAQ:ESTA) Director Sells $2,446,125.00 in Stock
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from Analysts
Insider Selling: Establishment Labs (NASDAQ:ESTA) Director Sells 3,575 Shares of Stock
Establishment Labs Holdings Inc. $ESTA Shares Acquired by Assenagon Asset Management S.A.
Quiros Juan Jose Chacon Sells 33,925 Shares of Establishment Labs (NASDAQ:ESTA) Stock
Bamco Inc. NY Purchases 274,287 Shares of Establishment Labs Holdings Inc. $ESTA
Rice Hall James Buys QuidelOrtho Stock
Rice Hall James Buys Stride Stock
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Recommendation of “Moderate Buy” from Brokerages
Establishment Labs targets at least 25% revenue growth in 2026 while expanding minimally invasive platforms
Establishment Labs GAAP EPS of -$0.09 beats by $0.13, revenue of $64.62M beats by $0.5M
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Q4 2025 Earnings Call Transcript
Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
Establishment Labs Announces Leadership Transition to Support Next Phase of Growth
Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24
Establishment Labs (NASDAQ:ESTA) & Q Biomed (OTCMKTS:QBIO) Critical Contrast
Establishment Labs: The Pivot From Growth To Profitable Scale
Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
Contrasting Establishment Labs (NASDAQ:ESTA) and Tauriga Sciences (OTCMKTS:TAUG)
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
ESTA Shares Dip Despite FDA Filing for Motiva Breast Reconstruction
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
Analyzing Omada Health (NASDAQ:OMDA) & Establishment Labs (NASDAQ:ESTA)
Financial Contrast: Establishment Labs (NASDAQ:ESTA) & XWELL (NASDAQ:XWEL)
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Recommendation of “Moderate Buy” from Analysts